全文获取类型
收费全文 | 9921篇 |
免费 | 310篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 126篇 |
儿科学 | 238篇 |
妇产科学 | 196篇 |
基础医学 | 1354篇 |
口腔科学 | 200篇 |
临床医学 | 813篇 |
内科学 | 1928篇 |
皮肤病学 | 114篇 |
神经病学 | 674篇 |
特种医学 | 472篇 |
外国民族医学 | 5篇 |
外科学 | 1470篇 |
综合类 | 166篇 |
一般理论 | 12篇 |
预防医学 | 666篇 |
眼科学 | 224篇 |
药学 | 830篇 |
中国医学 | 54篇 |
肿瘤学 | 739篇 |
出版年
2012年 | 1055篇 |
2011年 | 1033篇 |
2010年 | 165篇 |
2009年 | 106篇 |
2008年 | 874篇 |
2007年 | 919篇 |
2006年 | 897篇 |
2005年 | 888篇 |
2004年 | 900篇 |
2003年 | 800篇 |
2002年 | 665篇 |
2001年 | 482篇 |
2000年 | 656篇 |
1999年 | 267篇 |
1998年 | 26篇 |
1997年 | 17篇 |
1996年 | 18篇 |
1995年 | 16篇 |
1994年 | 10篇 |
1993年 | 8篇 |
1992年 | 8篇 |
1991年 | 9篇 |
1990年 | 7篇 |
1989年 | 4篇 |
1988年 | 3篇 |
1987年 | 6篇 |
1985年 | 5篇 |
1983年 | 4篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1978年 | 4篇 |
1975年 | 3篇 |
1974年 | 2篇 |
1967年 | 2篇 |
1963年 | 10篇 |
1961年 | 4篇 |
1960年 | 6篇 |
1959年 | 42篇 |
1958年 | 63篇 |
1957年 | 56篇 |
1956年 | 45篇 |
1955年 | 63篇 |
1954年 | 62篇 |
1953年 | 2篇 |
1949年 | 16篇 |
1948年 | 18篇 |
1947年 | 4篇 |
1946年 | 2篇 |
1944年 | 3篇 |
1941年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
Thompson KW 《Neuroscience》2005,133(4):1029-1037
Intractable seizures originating in the mesial temporal lobe can often be controlled by resection. An alternative to removing hippocampal tissue may be transplantation of GABA-producing cells. Neural cell transplantation has been performed in hundreds of patients, including some with temporal lobe epilepsy. This study evaluates the seizure-suppressing capabilities of engineered GABA-producing cells transplanted into the dentate gyrus. Immortalized neurons were engineered to produce GABA under the control of doxycycline. The cells were characterized for GABA production in vitro and for their ability to raise GABA concentrations in vivo. Cells were transplanted bilaterally into the dentate gyrus of rats and tested in two separate paradigms. Afterdischarge thresholds and durations were tested with granule cell stimulation, and the development of behavioral seizures, induced by daily electrical stimulation of the major excitatory input pathway into the dentate gyrus, was assessed in the presence, or the absence, of doxycycline. GABA production was under the tight control of doxycycline. Cells engineered to produce GABA raised tissue GABA concentrations in the hippocampus compared with non GABA-producing cells, and this was abolished when doxycycline was administered. GABA-producing cells raised the threshold, and shortened the duration of hippocampal afterdischarges elicited by granule cell stimulation. Lastly, the appearance of stage 5 seizures was slowed in the kindling paradigm, compared with a group that received non-GABA-producing cells, and compared with a group that received GABA-producing cells but was administered doxycycline. This study shows that targeted hippocampal implants of genetically engineered cells have the potential to raise GABA levels and to affect seizure development. The ability to suppress the production of GABA, and to modulate the physiological effects of the transplanted cells provides an important level of experimental control. These techniques, combined with stem cell technology, may advance cell-based therapies for epilepsy and other diseases of the CNS. 相似文献
8.
Lawrence SM Larsen JO Horch KW Riso R Sinkjaer T 《Journal of biomedical materials research》2002,63(5):501-506
Polymer-based longitudinal intrafascicular electrodes (polyLIFEs) were chronically implanted into the sciatic nerve of white New Zealand rabbits (n=8) for a period of 6 months (hereafter referred to as the long-term group). The impact of the implantation procedure, as observed 6 months post surgery, was evaluated in a sham-treated control group (n=9). The contralateral sciatic nerve served as the control for each animal. Nerve-fiber counts, fiber diameters, and myelin thickness were estimated at the level of the implant site, 1.5 cm proximally, and 1.5 cm distally for both nerves in sham-treated and long-term groups. Implantation of polyLIFEs had no significant effect on fiber counts, nerve-fiber diameter, or myelin thickness. A slight increase in connective tissue in the vicinity of the implant site was evident in the long-term group, including a thin but dense capsule immediately surrounding the implanted electrode. 相似文献
9.
Yu WH Zhao KW Ryazantsev S Rozengurt N Neufeld EF 《Molecular genetics and metabolism》2000,71(4):573-580
The Sanfilippo syndrome type B (MPS III B) is an autosomal recessive disease caused by deficiency of alpha-N-acetylglucosaminidase (EC 3. 2.1.50), one of the lysosomal enzymes required for the degradation of heparan sulfate. The disease is characterized by profound neurodegeneration but relatively mild somatic manifestations, and is usually fatal in the second decade. A mouse model had been generated by disruption of the Naglu gene in order to facilitate the study of pathogenesis and the development of therapy for this currently untreatable disease. Recombinant human alpha-N-acetylglucosaminidase (rhNAGLU) was prepared from secretions of Lec1 mutant Chinese hamster ovary cells. The enzyme, which has only unphosphorylated high-mannose carbohydrate chains, was endocytosed by mouse peritoneal macrophages via mannose receptors, with half-maximal uptake at ca. 10(-7) M. When administered intravenously to 3 month-old mice, rhNAGLU was taken up avidly by liver and spleen but marginally if at all by thymus, lung, kidney, heart, and brain (in order of diminishing uptake). The half-life of the enzyme was 2.5 days in liver and spleen. Immunohistochemistry and electron microscopy showed that only macrophages were involved in enzyme uptake and correction in these two organs, yet the storage of glycosaminoglycan was reduced to almost normal levels. The results show that the macrophage-targeted rhNAGLU can substantially reduce the body burden of glycosaminoglycan storage in the mouse model of Sanfilippo syndrome III B. 相似文献
10.
Okamoto T Jeong SY Takahashi Y Baughman KW Ogata K Goto J Kanazawa I 《International journal of molecular medicine》2001,8(4):413-416
Calcium channel blocker is useful for a variety of purposes and is effective for preventing hepatitis elicited by different inducers, suggesting its possible clinical application for treating hepatitis. The alpha1-subunit of the dihydropyridine-sensitive L-type calcium channel is a target of calcium channel blocker. For clinical application of calcium channel blocker, it is important to analyze the expression of the L-type calcium channel in the liver. However, the subtype of the L-type calcium channel alpha1-subunit expressed in the liver was not known. In the present study, the alpha1-subunit of the calcium channel expressed in human liver was systematically analyzed. The alpha1D subunit of the dihydropyridine-sensitive L-type voltage gated calcium channel is expressed relatively strongly in the liver and may play an important role in the liver. 相似文献